KATHRYN KESTI: Open Payments
NPI 1124651443 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,348 in 359 payments from 32 companies in 2025. Trend: 2023 $7,616 · 2024 $8,864 · 2025 $9,348
Food & beverage: $4,746Speaker / faculty: $4,500Education: $102
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 71 | $5,344 |
| Teva Pharmaceuticals USA, Inc. | 34 | $409 |
| UCB, Inc. | 37 | $409 |
| Novartis Pharmaceuticals Corporation | 34 | $401 |
| Lundbeck LLC | 27 | $362 |
| PFIZER INC. | 26 | $299 |
| Neurocrine BioSciences, Inc. | 21 | $286 |
| Biogen, Inc. | 22 | $233 |
| ARGENX US, INC. | 9 | $169 |
| CSL Behring | 11 | $163 |
Products named: QULIPTA, UBRELVY, KESIMPTA, VYEPTI, AUSTEDO XR, INGREZZA, BOTOX, NURTEC ODT.
Industry payments across NE — which companies pay providers there.
